The Type dimension of the Biotech Flavor market is commonly divided into three sub‑categories: microbial‑derived, enzyme‑modified, and plant‑extracted flavors. Microbial‑derived flavors, produced through fermentation of genetically engineered microorganisms, dominate the segment by accounting for roughly 60 % of total revenues, driven by their scalability and consistent supply chain. Enzyme‑modified flavors, which involve biocatalytic conversion of precursor compounds, contribute about 25 % of market value; they are favored for their ability to generate novel taste profiles while reducing processing steps. Plant‑extracted flavors, obtained from natural sources using biotechnological extraction methods, represent the remaining 15 %, reflecting a niche but growing demand for clean‑label ingredients. Each type adds distinct cost structures, regulatory pathways, and performance characteristics, collectively shaping the overall market size and informing investment decisions across the sector.